INTRODUCTION
Many premature infants cannot tolerate full enteral feeding due to an immature gastrointestinal tract.
Parenteral nutrition (PN) is critical in these babies to avoid nutritional deficiencies, promote growth, and to achieve normal maturation. However, PN can lead to hepatic metabolic complications such as cholestasis within 2 weeks of PN administration (1) , and 90% of infants who receive PN for greater than 3 months develop parenteral nutrition associated liver disease (PNALD) (2) . Limiting the lipid load administered to premature infants has been shown effective in preventing the onset of cholestasis (3) . However, infants require sufficient caloric intake to achieve appropriate growth and neurodevelopment (4), so the option to limit the PN lipid to prevent PNALD is not ideal. For these reasons, it is important to understand the process of PNALD development in this neonatal population.
The lipid fraction of PN solutions has been a target of research to understand the development of PNALD.
Soybean-based lipid emulsions are the prevalent lipid emulsion used in the US and approved by the FDA for clinical use in neonates, but has been associated with PNALD (5) . TPN solutions that contain fish oil-based emulsions have been associated with prevention of cholestasis and reversal of cholestasis in some limited studies (6, 7) , but the basis for these observations is not clear. Some research suggests that phytosterols, a component of soy lipid emulsions, can suppress bile acid synthesis and impact bile acid efflux target genes in the liver through inhibition of the nuclear hormone receptor farnesoid x receptor (FXR). A recent report by El synthesis through repression of sterol regulatory binding protein (SREBP) (10) and carbohydrate responsive element binding protein (CHREBP) (11) , respectively. Omega-3 fatty acids are also capable of activating the nuclear hormone receptor, peroxisome proliferator-activated receptor alpha (PPARα), to upregulate downstream target genes of fat oxidation in both mitochondria and peroxisomes (12, 13) . In addition, omega-3 fatty acids promote the formation of anti-inflammatory prostaglandins, eicosanoids, and resolvins (14) . It is likely that improved steatohepatitis, and glucose sensitivity observed in adults administered omega-3 treatments are due to a combination of these targeted effects (15, 16) . However, there is limited evidence in preterm infant studies describing how these markedly different fatty acids present in new generation parenteral lipid emulsions alter tissue fatty acid profiles and metabolic function, especially in the liver.
As with omega-3 fatty acids, clinical trials in adults have shown that vitamin E protects against non-alcoholic fatty liver disease (NAFLD) (17) and chronic hepatitis C (18) . In NAFLD, free fatty acids can induce reactive oxygen species ROS causing mitochondrial dysfunction, including reduced fatty acid β-oxidation (19) . This reduced β-oxidation capacity can trigger a compensatory increase in activity of hepatic peroxisomal and microsomal fatty acid oxidizing enzymes like cytochrome P450 2E1 (CYP2E1) that generate large amounts of hydrogen peroxide (20) . A key protective function of vitamin E is its strong antioxidant activity that confers defense against ROS-mediated lipid peroxidation (21) . In addition, there is evidence suggesting that natural vitamin E (RRR-α-tocopherol and δ-and γ-tocopherol) can act as ligand for the pregnane X receptor (PXR) and activate xenobiotic metabolic pathways (22) . Treatment with the PXR agonist, rifampicin, has been shown beneficial in the treatment of pruritus of cholestasis (23) . The effect of new generation lipid emulsions on the vitamin E status in preterm infants and enrichment in tissue such as the liver is poorly understood.
In our previous report, we established that new generation lipid emulsions containing fish oil and vitamin E lead to decreased indices of liver damage and lipid accumulation (7) . In this paper, we have taken a multi-omics approach to examine the effect of those lipid emulsions on whole body metabolism, fatty acid utilization, and lipidomic and metabolomic profiles in the liver and muscle tissue in our PN-fed piglet model. Our second aim by guest, on October 14, 2017 www.jlr.org
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was to characterize the impact of these different lipid emulsions on hepatic gene networks using a genome-wide, transcriptomic analysis.
MATERIALS AND METHODS

Animals and surgery
The study protocol was approved by the Animal Care and Use Committee of Baylor College of Medicine and was conducted in accordance with the Guide for the Care and Use of Laboratory Animals (DRR/NIH, Bethesda, MD). Sows were obtained from the Texas Department of Criminal Justice (Huntsville, TX) and housed in the Children's Nutrition Research Center. Our surgical protocol has been previously described (7) . Briefly, domestic crossbred piglets were delivered 7 day preterm on gestation day 108 by caesarian section. Piglets were administered injections of iron dextran (100 mg/mL), ampicillin (125 mg/mL), and buprenorphine (0.3 mg/mL) prior to surgery. Piglets received either enteral nutrition or three forms of TPN. Saline or TPN was administered via surgically implanted jugular and umbilical arterial catheters. Enterally fed piglets were implanted with an orogastric feeding tube and TPN groups received a sham puncture.
Nutritional support and study design
TPN consisted of a solution containing a complete nutrient mixture of amino acids, glucose, electrolytes, vitamins, and trace minerals, administered via jugular catheter, and a parenteral lipid emulsion, which was infused separately via umbilical arterial catheter. Piglets in the TPN groups randomly received one of the following lipid emulsions: 100% soybean oil (IL) (20% Intralipid), 100 % fish oil (OV) (Omegaven), or a mixture of 30% soybean oil, 30% medium chain triglycerides (MCTs), 25% olive oil, and 15% fish oil (SL) (SMOFlipid); all three lipid emulsions were provided by Fresenius Kabi (Bad Homburg, Germany). ENT piglets were fed a milk-based formula (Litter Life; Merrick, Middletown, WI) at 240 ml/kg in eight feeds per day (24) . Post-surgery, TPN was started at 5 ml/(kg·h) and gradually increased to 10 ml/(kg·h). ENT piglets also received TPN with IL following surgery but were started on enteral feeds on day of life 2 and gradually by guest, on October 14, 2017 www.jlr.org Downloaded from weaned off TPN. On day 7, all TPN and enterally fed piglets received full amounts of nutrition per kilogram body weight: fluid, 240 ml; energy, 195 kcal; carbohydrate, 25g; protein, 14 g; and lipid, 5g, as described (7).
Piglets were weighed every other day, and blood samples were drawn during surgery (day 0) and day 14.
Immediately after the last blood sample was taken on day 14, the animals were anesthetized with isoflurane and euthanized with injection of Beuthanasia (pentobarbital sodium, phenytoin sodium). Organs were isolated and weighed. Liver tissue samples were frozen in liquid nitrogen and stored at -80ºC until analysis. Liver samples also were fixed in OCT for histopathology.
Sample preparation and analysis
Blood samples were collected in Na 2 EDTA tubes and centrifuged for 10 min at 2000 x g in 4ºC. Samples were flash frozen in liquid nitrogen and stored at -80ºC until analysis. Glucose and insulin were analyzed as previously described (24) . As piglets were on continuous TPN infusion, they receive a constant glucose infusion rate. Utilizing this, we performed HOMA-IR calculations with the HOMA2 formula (25) : HOMA-IR = (glucose mmol/L x insulin µU/ml)/22.5. For serum cholesterol, triglyceride, and lactate dehydrogenase (LDH), analysis was performed on a Cobas Integra 400 plus analyzer (Roche).
Indirect calorimetry and [1-
C]-palmitate fatty acid oxidation
For measurements of respiratory exchange ratio (RER), heat production, and 13 CO 2 , piglets were placed in air-tight calorimetry chambers (Columbus Instruments) and measurements were performed as described previously (26) . Specifically for 13 CO 2 analysis, on day 11 piglets were placed in a calorimetry chamber and administered [1- 
Fatty acid analysis
Total fatty acids were isolated from plasma and tissues using a modified method from Folch (27) . Briefly, 20-150 mg tissue samples were homogenized in 1-2 mL PBS. Plasma samples (200 µL) were diluted with 500 µL PBS. Samples were extracted from plasma and tissues (500 µL) by the addition of chloroform-methanol (2:1 vol/vol). The samples were then incubated for 10 mins on ice, and then spun at 2500 rpm for 10 min. The top layer was discarded and the remaining sample was dried under nitrogen gas. Methanolic NaOH (0.5 mL, 0.05 M) was added to the dried sample and incubated for 3 min at 100ºC, followed by addition of 0.5 mL BF 3 -methanol. The samples were heated for an addition 1 min at 100ºC, then 1 mL hexane and 6.5 mL saturated NaCl were added. Samples were vortexed and spun at 1700 rpm for 4 min. The upper hexane phase was used for analysis. Quantification of fatty acid methyl esters was performed on a gas chromatograph (HP5890 Series II, Hewlett-Packard) equipped with a SP-10 capillary column (Supelco) attached to a mass-spectrometer (HP-5971, Hewlett-Packard).
Vitamin E analysis
Vitamin E (α-tocopherol and γ-tocopherol) in plasma and liver was analyzed as described previously (28, 29) .
In brief, liver tissue was homogenized in two volumes of ethanol with an Ultra-Turrax homogenizer on ice. used to obtain the identification and quantification of the tocopherol.
RNA Sequencing
RNA was extracted from liver tissue using TruSeq RNA Sample Preparation Kit v2 (Illumina) and sequenced using Illumina RNA Hi-seq 2000. Sequencing data was analyzed using a series of software tools which included Bowtie, tophat, cufflinks package -cufflinks, cuffcompare, cuffmerge and cuffdiff (30) . These generated lists of differentially expressed and regulated genes and transcripts. Piglet genome Sus scrofa 10.2.68 from Ensembl (http://www.ensembl.org/Sus_scrofa/Info/Index) was used as a reference. Cutoff values for significance were fold change > ±1.5, P < 0.05 and q < 0.1. Analyzed data was subjected to Ingenuity Pathway Analysis (IPA) www.ingenuity.com.
Metabolomics Analysis
Acyl-CoA's (AC), acyl-carnitines (ACT) and organic acids (OA) were analyzed by targeted mass spectrometry. For preparation of tissue samples for AC and OA content, tissues were homogenized in 50% aqueous acetonitrile containing 0.3% formic acid. OAs were analyzed by Trace Ultra gas chromatography coupled to a Trace DSQ mass spectrometry using a stable isotope dilution method described previously (31, 32) .
For analysis of long-chain ACs, chloroacetaldehyde was added to the homogenate and samples were separated by high-performance liquid chromatography and then detection of individual ACs was done fluorimetrically (33) . For ACT analysis, samples were homogenized in H 2 O and analyzed by flow injection tandem mass spectrometry (MS/MS) as described previously (34) . Mean absolute concentrations of each metabolite were then transformed using base package in R (R Foundation for Statistical Computing, Vienna, Austria, URL http://www.R-project.org). Clustering heatmaps were created using the heatmap.2 function in gplot (35) , in conjunction with Mkmisc (36) , and Rcolor (37).
Real-time PCR
Quantitative real-time PCR was performed on frozen liver samples. The cDNA was generated from RNA extracted from 100 to 150 mg of frozen liver tissue as described previously (7) . Real-time qPCR was performed with Sybr green chemistry (Applied biosystems) on a Bio Rad CFX96. Primers were designed using software from NCBI Primer Blast. The primers for porcine Aox1, Cyp2e1, Cyp1a2, Fmo5, Il-1β, Il-6, Tnf, and Il-8 (Supplemental Table 1 ) were designed using the predicted porcine sequence available on Ensemble Genome Browser (Gene ID: ENSSSCG00000012871). Amplification efficiency was controlled by the use of an internal control (GAPDH or actin). Relative quantification of target mRNA expression was calculated and normalized to GAPDH or actin expression. All reactions were performed under the following thermal cycling conditions: 10 min at 95ºC followed by 40 cycles of 95ºC for 15 s and 60ºC for 60 s. The 2 -ΔΔCT method was used to compare gene expression levels between samples, which were analyzed to determine the fold induction of mRNA expression.
STATISTICS
Statistical analyses were performed using SPSS 16 software (Armonk, NY). Differences among the four groups were first analyzed using one way ANOVA, and post-hoc analysis was done using Tukey's test as described in the figure legends. For results that were not of normal distribution, the nonparametric Kruskal-Wallis ANOVA on Ranks followed by pairwise comparisons using Dunn's test was used to determine significance. P values < 0.05 were considered significant. Results are presented as mean ± SEM.
RESULTS
Following 14 days of ENT or TPN administration, body weight and tissue weights differed in piglets between experimental treatments ( Table 1) . Body and liver weights were previously published, but included in this analysis for continuity and comparison with other tissue weights (7) . Growth rates (g/(kg·h)) were significantly decreased (P < 0.05) in the IL group versus other treatments. Jejunum and ileum weights were significantly lower, whereas liver and spleen weights were higher in the TPN administered groups compared to ENT (P < 0.05). The pancreas weight was lower (P < 0.05) in the OV and SL groups compared to ENT, but IL were significantly lower in all three TPN groups compared to ENT. Insulin was significantly elevated (P < 0.05) in the IL piglets compared to ENT piglets. OV insulin was moderately elevated, but non-significant, whereas insulin levels in ENT and SL piglets were not different. Calculated HOMA-IR ratios show a similar pattern as insulin with significant elevation in the IL group compared to ENT.
To assess whether change in body weight was contingent upon the metabolic activity and lipid content of the emulsions, energy expenditure and fat oxidation using 13 C-palmitate were measured (Fig. 2) . Respiratory exchange ratio (RER) of the OV treated piglets was significantly (P < 0.05) greater than ENT, IL, and SL.
Overall, the RER was high in all groups (> 90%). Heat production, as an indicator of metabolic activity, was not different between any groups. During steady-state, the rate of 13 C-palmitate oxidation to 13 CO 2 did not differ between groups, although there was a slight trend for elevated 13 CO 2 in the OV group.
Distribution of fatty acids from the diets was examined as well as the tissue enrichment of those fatty acids in the liver, brain, and muscle (Supplemental Table 2, Table 2, Table 3, and Supplemental Table 3 , respectively). The overall percent fatty acid composition differed significantly among the four treatment groups. ENT and IL diets lacked polyunsaturated fatty acids (PUFAs), EPA and DHA, whereas OV was highly enriched with 19.9% and 17.3%, respectively, in those fatty acids. Percent enrichment of palmitic acid (16:0) was greatest in the ENT diet. The percent enrichment of linoleic acid (LA, 18:2n-6) was greatest in the IL emulsion (36%) with very limited enrichment in both OV and SL with 3.9% and 11.8%, respectively. The content of MCT in SL diet was markedly higher than that of ENT, IL, or OV. Caprylic acid (8:0) and capric acid (10:0) comprised 31.0% and 12.7% of SL lipid emulsion, respectively. The pattern of fatty acid enrichment in both the liver ( Table 2 ) and muscle (Supplemental Table 3 ) tissues mirror the dietary (Supplemental Table   2 ) fatty acid patterns, except for the medium chain fatty acids.
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The brain ( Table 3 ) tissue showed significant (P < 0.05) enrichment of DHA in the OV and SL groups compared to ENT and TPN. The AA concentration in the ENT groups was moderately, but significantly higher (P < 0.05), compared to the OV and SL groups. The distribution of fatty acids in the brain mirrored results seen in the retina (data not shown), with a trend to resemble the concentration of lipids found in the diets.
Within the muscle there were fewer differences in fatty acid enrichment among the ENT and TPN treatments.
Linoleic acid was significantly (P < 0.05) different between ENT, IL, and, OV (11.21 ± 0.75%, 26.30 ± 1.51%, and 1.80 ± 0.13%, respectively). DHA, like in the liver, was significantly (P < 0.05) higher in OV (10.67 ± 0.84%) compared to ENT (0.31 ± 0.02%). SL had the fewest differences in fatty acid profile compared to the ENT group, but did have 8-fold higher percent DHA enrichment (P < 0.05) than ENT. The SL group had significantly lower (~50%) linoleic acid compared to IL (13.82 ± 0.84 vs. 26.30 ± 1.51%). Table 4 , 5, and Table 4 ). The most pronounced changes relative to ENT nutrition occurred in the OV group. After 14 d, the increase in linoleic acid was significantly (P < 0.05) less in OV vs.
Plasma fatty acid concentrations were markedly different after 14 d administration of the various lipid emulsions (Supplemental
ENT piglets (5.42 ± 0.62 % and 21.42 ± 0.64 %). In the ENT and IL groups, there was a significant decrease in DHA (-2.45 ± 0.14 % and 0.79 ± 0.08%, respectively), whereas DHA was markedly increased in the OV and SL groups (6.56 ± 1.02 % and 2.67 ± 0.24 %, respectively). The EPA proportion did not change after 14 d in the ENT and IL groups, but was significantly (P < 0.05) elevated in OV group by 6.62 ± 0.72%. EPA plasma content was elevated in SL group, but did not achieve statistical significance. We further examined the different fatty acid compositions of the lipid emulsions by calculating the ratio of n-6:n-3 fatty acids and LA:DHA (Fig.   3 ). From d 0 to d 14, ENT and IL groups had a significant (P < 0.05) increase in plasma proportion of n-6 fatty acids, whereas OV and SL had a significant (P < 0.05) decrease in n-6:n-3 ratio. Between treatment groups at d14, the n-6:n-3 ratios IL, OV and SL ratios were significantly (P < 0.05) different than ENT. OV treatment resulted in the lowest n-6:n-3 ratio and was significantly (P < 0.05) different from IL and SL. The SL group n-6:n-3 ratio was also significantly (P < 0.05) lower than the IL group. The linoleic:DHA ratio in the ENT group The concentrations of sphingosine and ceramide also were assessed in the diet, plasma, and liver (Supplemental Fig. S1 ). Ceramide was markedly elevated in the IL compared to OV or SL groups. However, liver and plasma ceramide levels did not differ significantly between any of the TPN groups, although there was a trend towards lower plasma ceramide in the SL group. Dietary sphingosine was lower in the SL compared to the IL and OV groups, and plasma sphingosine was elevated in all three TPN groups compared to ENT. Plasma sphingosine was highest in the IL group, (P < 0.05). Liver sphingosine levels did not differ though between the ENT and TPN groups.
As there is increasing interest in the functional impact of vitamin E in TPN administration to prevent the onset of PNALD, we measured the concentration of the main biologically active form of vitamin E, α-tocopherol, and its various stereoisomers as they are distributed in the plasma and liver following 14 d TPN administration ( Table 5) . Total plasma α-tocopherol was more than 2-fold (P < 0.05) lower in the IL treatment group vs. ENT. In SL it was also significantly (P < 0.05) lower in α-tocopherol with 3.12 ± 0.39 µg/g compared to an ENT concentration of 4.61 ± 0.24 µg/g. The dominant stereoisomer form of α-tocopherol in IL was RRR-α-tocopherol, which comprised 95.7 % of the total α-tocopherol in the plasma, which was significantly higher than the other groups; i.e. 24.3% (ENT), 22.2% (OV), and 30.4% (SL) of the total α-tocopherol in plasma ( Table 5 ). The plasma 2S forms of α-tocopherol contribution to total α-tocopherol content in the OV (26%) and the SL (20.8%) treatment groups was markedly higher compared to that of ENT (12.4%) and IL (0.53%). In the liver, there was a significant (P < 0.05) higher concentration of α-tocopherol in the OV and SL groups compared to ENT for total α-tocopherol. Gamma-tocopherol was measured in the liver piglets in the IL, but was not detectable in the liver of the piglets in the other groups. The RRR-α-tocopherol contributed with 96% of the total α-tocopherol in the IL group, whereas other groups had around 20 % of RRR-α-tocopherol. In absolute concentrations, both OV and SL had high RRR-α-tocopherol enrichment at 40.8 ± 0.36 μg/g and 28.9 ± 1.10 μg/g, respectively; yet, this was a non-significant enrichment compared to ENT. The proportion of 2S-α-tocopherol in the liver differed in the liver, and was significantly lowest for the IL (1.6%), and higher for the ENT (22.5%), OV (35%) and SL (42%). CoAs. Like liver, muscle tissue also had an abundance of very small chain acyl CoAs, but no significant differences in the relative concentrations of different acyl CoAs were observed. Also relative to the liver, fewer acyl CoAs were detected.
Free carnitine in the plasma, liver, and muscle was significantly reduced in TPN groups compared to the ENT group (Fig. 5) . Within the liver, 18 of the 66 ACT's were significantly (P < 0.05) higher in the ENT treated group compared to the TPN groups. However, only 3 of the 66 ACTs in the muscle were significantly elevated in the ENT treatment vs TPN. The most abundant ACTs in all 4 groups in liver and muscle were the small chain ACTs. OV treatment significantly (P < 0.05) increased the ACT, C12:1-OH/C10:1-DC, compared to ENT, IL, or SL in the liver tissue only. SL treatment led to a significant increase in the MCT C10:2 in the liver and C6 and C6-DC/C8-OH in the muscle.
Organic acid (OA) concentrations show little change between the ENT and TPN treatments (Supplemental To gain insight into the effects of TPN treatment on gene expression in the liver, RNA sequencing was performed (Fig. 6) . The number of genes that significantly differed from ENT group among the three TPN treatments were compared and visualized in a Venn diagram. Total number of genes that differed from ENT was 115, 101, and 15 in IL, OV, and SL, respectively. Overall, 11 overlapping genes were altered in all three TPN groups vs the ENT groups which included Aox1, Dak, Derl3, Hamp, Id1, Lcn2, Mfsda2a, S100g, Serpine1, Tmem86b and Ubd. Canonical unbiased pathway analysis of the genes altered by IL treatment compared to ENT was performed. Of the 10 top pathways, oxidative degradation, oxidative stress, immune response and lipid metabolism were recurrent. The nicotine degradation pathway that is reliant upon CYP450 pathway genes and other oxidation genes was the most significant pathway. Other pathways associated with nuclear hormone receptor activity, LXR/RXR activation, and inflammatory response, acute phase response, were also altered by IL administration. Target genes that were enriched in multiple pathways from IPA analysis were confirmed using qPCR (Fig. 7) . The expression of most of the genes was consistent with results obtained from the RNA seq; however, LXR (Nr1h3) was not significantly different in any treatment following qPCR. Additional genes not directly seen in the RNA seq results were also examined that are associated with nuclear hormone receptors that regulate lipid metabolism. Whereas most genes failed to show significance, Srebp1c was significantly (P < 0.05) decreased in all TPN groups compared to ENT.
We measured the expression of inflammatory cytokines to test whether there was a lipid treatment-specific effect on cytokine expression (Fig. 8) . At the transcript level, Il-6 was the only cytokine that differed among treatment groups. In the IL group, Il-6 expression is 2-fold greater (P < 0.05) than ENT.
DISCUSSION
TPN is necessary as a life-saving intervention in many premature and GI tract-compromised infants.
Considerable evidence suggests that the lipid component of TPN is linked to the complications that culminate in the development of PNALD. Recent attention has focused on how soybean oil-based emulsions (e.g. Intralipid) may contribute to PNALD and we recently reported that new generation lipid emulsions (e.g. Omegaven and SMOFlipid) can prevent PNALD in preterm piglets (7) . Beyond the impact on hepatic metabolism, lipid nutrition makes a major contribution to the whole-body energy needs, fatty acid requirements, immune-and metabolic function in developing neonates. In this study, we performed comprehensive analysis of lipidomics, metabolomics, and transcriptomics profiling of tissues in PN-fed preterm piglets given three parenteral lipid emulsions with different lipid constituents including n-6 vs. n-3 PUFA, vitamin E, and sphingolipids.
Lipid emulsions are administered to premature infants to achieve optimal growth by providing a balanced, high energy parenteral nutrient intake that minimizes hyperglycemia. In this study using premature piglets to model metabolism of premature infants, we found that IL produced the lowest growth rates, whereas growth of OV and SL were similar to ENT piglets. Interestingly, the lower growth rates of IL piglets occurred despite a differential increase in tissue mass of liver, heart and spleen, and decrease in intestinal growth in all PN groups relative to ENT. Moreover, the presence of hepatomegaly in all PN groups occurred despite the prevention of steatosis and cholestasis in the OV and SL vs. IL piglets (7). Our previous study also showed that TPN-induced hepatomegaly was due to increased protein and DNA, but not lipid content (24) . The differential increase in these vital organs among all PN groups, but lower body growth rates in IL vs. OV and SL piglets points to a limitation in lean/skeletal muscle growth, which we reported previously (24) . A major concern of PN-fed premature infants is the growth and neurodevelopment of the brain. The high LA content of IL has been linked to increased risk for inflammation and potential neurodevelopmental complications, whereas AA and DHA are major constituents of brain lipid composition and diets low in AA and DHA are considered a potential risk for impaired brain development in premature infants (38, 39). In light of these considerations, we were surprised that brain mass among all four treatment groups did not differ, and especially given that emulsions OV and SL are enriched in DHA, the LC-PUFA considered essential for normal perinatal neurodevelopment. Our data does not exclude the possibility that differences in brain function and neurodevelopment may still be affected by the fatty acid composition of the lipid emulsions. These are piglets that did receive a processed, cow's milk formula, not natural sow's milk, which might also account for the lack of difference between the ENT and TPN groups.
An important metabolic finding was that TPN administration with IL led to hyperinsulinemia and insulin resistance compared to ENT piglets, confirming our previous work (24) , but this phenotype was diminished with OV and SL. We previously showed that insulin resistance with IL was due to impaired insulin signaling and by guest, on October 14, 2017 www.jlr.org Downloaded from was associated with increased hepatic inflammation, and thus it was notable in the current study that we found that hepatic IL-6 expression was highest in IL vs. OV and SL piglets (40). The explanation for lower hepatic inflammation could be due to the anti-inflammatory and anti-oxidant effects associated with higher liver enrichment of n-3 PUFAs, DHA and EPA, as well as α-tocopherol in the OV and SL vs. IL piglets (24, 41, 42) .
The tissue and plasma fatty acid profiles generally reflected the pattern of fatty acids present in the lipid emulsions consistent with prior piglet studies (43, 44). In contrast to these previous reports, we found significant enrichment of DHA and EPA in brain tissue in OV and SL vs. IL and ENT piglets. Long chain polyunsaturated fatty acids (LC-PUFAs) are necessary for normal development of the central nervous system and possibly also other organ systems (45). Formation of DHA from α-linolenic acid (ALA) is limited and highly variable, and DHA may be considered conditionally essential during early development (46). This is especially important for preterm infants who are born at a stage of gestation before the normal placental transfer and deposition of DHA in fetal tissues are completed. This loss of fetal DHA transfer due to preterm birth may be difficult to restore by current nutritional practices and result in a "DHA gap of prematurity" (6, 9). The challenge of restoring this DHA gap in premature infants is further complicated when enteral feedings are delayed and lipid intake is exclusively via parenteral lipid emulsions. In contrast, the capacity of the piglets to synthesize AA appears to remain intact as the percentage of AA in the ENT, IL, and SL diets at low concentrations, yet both the liver and muscle have substantial AA contents. In piglets, synthesis of DHA from ALA is greatly improved with a low LA:ALA ratio (43). High LA concentration competes with ALA for desaturases to form LC-PUFAs. The higher AA in the ENT and IL groups may in part be due to the high LA content suppressing overall DHA synthesis as well as leading to the observed elevation in AA. This study does show there is some functional capacity for LC-PUFA synthesis from precursor linoleic acid, or release from body stores is sufficient at 2 weeks of age in premature piglets. Also, our data suggest that premature piglet tissues have the capacity to readily take up preformed DHA and EPA given parenterally, especially DHA uptake in the brain.
Ceramide concentrations have been implicated in the development of obesity and non-alcoholic fatty liver disease (47, 48). It was therefore interesting to see the high concentration of ceramide in the IL emulsion and the lack of ceramide in OV. Very low levels of ceramide were found in SL. However, the concentration of liver and plasma ceramide levels did not appear to differ between the treatment groups. The downstream metabolite of ceramide, sphingosine did not show any difference in content in the liver either. It would therefore not seem that the excess ceramide in IL was shunted toward this metabolic pathway. The exact metabolic pathway of excess ceramide is not clear at this point. The presence of ceramides in the IL emulsion does represent a unique finding that does warrant further study for the potential negative role it could play in the development of PNALD.
Vitamin E was initially added to the new generation lipid emulsions as manufacturers were concerned about the degree of lipid peroxidation that would occur to the long chain PUFAs, such as EPA and DHA. For this reason, both OV and SL have much higher concentrations of vitamin E compared to IL. The vitamin E concentration in IL was insufficient to maintain plasma levels similar to that seen in piglets on the ENT diet. In accordance with our previous study (32) , the IL group had a considerable hepatic concentration of γ-tocopherol, whereas γ-tocopherol was not detectable in liver of other groups, or in plasma. The contribution of γ-tocopherol, and the stereoisomer composition of α-tocopherol in plasma and liver tissue in the IL vs OV and SL probably reflected the difference in the chemical forms of vitamin E in the emulsions. The low plasma α-tocopherol level of IL piglets are in agreement with clinical observations on the status of serum vitamin E in patients receiving IL compared to healthy controls (49). Vitamin E (α-tocopherol) is a key antioxidant for cellular function, so an increase in circulating α-tocopherol and incorporation into cellular membranes may play a role in the benefit derived from both the OV and SL groups in our study. The concentration of α-tocopherol/mol% total unsaturated fatty acids was 3 times higher in the OV and 2.3 times higher in SL compared to IL. At the same lipid dose of 5 g/(kg·d), we recently showed prevention of cholestasis in preterm piglets by supplementing IL with vitamin E to concentration equivalent to those present in OV (32) . However, a recent publication in term piglets administered IL supplemented with vitamin E at 10 g/(kg·d) failed to show any effect on treatment (50). Myristic acid has been shown to increase the activity of Δ-6-desaturase and increase accumulation of DHA in tissues (51-53). At this point, we have no direct data to suggest myristic acid activation of Δ-6-desaturase is driving the synthesis of DHA in preterm piglets, but this observation warrants further inquiry in our preterm model. The acetyl-CoA concentration was high in both liver and muscle, yet the content of acetylcarnitine in the liver and muscle was significantly higher in the ENT group compared to the TPN groups. The free carnitine in the plasma, liver, and muscle was also significantly lower in all TPN vs ENT groups. Additionally in the liver, multiple acyl-carnitines were elevated in the ENT group compared to TPN groups reinforcing the evidence of depleted carnitine pools in the latter. Carnitine is a key co-transporter for efficient uptake of fatty acids into the mitochondria for β-oxidation. Our results confirm earlier reports that the circulating carnitine levels decreased in TPN-fed infants reflect low carnitine stores and inadequate capacity for carnitine biosynthesis (54).
We measured the carnitine content of the diet of ENT piglets (53.95 nmol/g diet) and found that the concentration in the plasma of these piglets was higher than what could be achieved from the diet alone. This suggests that the endogenous synthesis of carnitine is activated by enteral feeding and that signaling is lost during TPN. Interestingly, despite the diminished tissue carnitine pools in the TPN vs. ENT groups, there were no differences observed in either the whole body palmitate oxidation rate or the RER. The RER was relatively high in all groups including the ENT group indicative of greater carbohydrate utilization. Similarly, there were by guest, on October 14, 2017 www.jlr.org Downloaded from no major changes in citric acid cycle intermediates among TPN groups, suggesting no overt changes in energy metabolism through this pathway in response to different lipid emulsion composition.
The hepatic transcriptomic profiles between piglets on ENT compared to IL emulsion revealed changes in pathways associated with oxidative stress response, inflammation, and alternative fatty acid oxidation pathways.
The activation of oxidative stress pathways and inflammation were consistent with an insulin resistant phenotype (55) and PNALD development (56) . High LA present in IL is also consistent with the increase in oxidative stress and inflammation (57) . The hepatic triglyceride accumulation observed in these piglets (7) led to increased fatty acid flux-mediated mitochondrial respiratory chain dysfunction resulting in increased oxidative stress (19) . To compensate for elevated oxidative stress, an increase in Sod2 in steatohepatitis is known to occur (58) and was increased in our piglet model. Interestingly, genes up-regulated in nonalcoholic steatohepatitis in various animal models, Aox1 and Cyp2e1, were down-regulated in the TPN groups (59, 60) .
The latter is in accordance with Fisher et al. who showed liver biopsies of patients with increasing severity of steatohepatitis had decreasing expression of Cyp2e1 (61) and suggest an effect of duration of disease.
Alternatively, liver immaturity in premature infants on TPN may lead to a transcriptomic profile similar to more severe steatohepatitis. Nevertheless, TPN clearly suppresses genes of alternative pathways of fat oxidation. It is also interesting that the expression of Srebp1c is also reduced, as this is a key regulator of lipogenesis. Taken together, there is an overall dysregulation of fat metabolism-associated genes in the TPN treated piglets.
In conclusion, our results provide valuable lipodomic, metabolomic, and transcriptomic profiles of preterm piglets fed TPN with lipid emulsions containing different fatty acid compositions. We show that the soybean oilbased emulsion (IL) that is high in the ratio of n-6:n-3 fatty acids results in lower body growth, lower α-tocopherol status, increased insulin resistance, and increased hepatic fat and inflammation compared to piglets fed enterally or TPN with other new generation lipid emulsions. The reduced growth in IL vs OV or SL groups was not reflected in diminished growth of specific organs measured suggesting an overall suppression of lean skeletal muscle growth. As predicted, we found that the types of fatty acids infused parenterally were reflected in the tissue fatty acids, even in the brain, but we found no evidence that TPN per se or lipid emulsion fatty acid Significantly different acyl-CoAs by treatment are highlighted with colors corresponding to the given treatment. n = 7-12 piglets per group; Green, P > 0.05 vs ENT; Red, P > 0. 05 
